Compounds > valproic acid

valproic acid and pd 0325901

valproic acid has been researched along with pd 0325901 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, S; Choi, H; Heo, YT; Kim, J; Kim, NH; Quan, X; Xu, YN1
Chen, Y; Cui, G; Li, M; Meng, F; Yu, Z; Zhang, Y1

Other Studies

2 other study(ies) available for valproic acid and pd 0325901

ArticleYear
CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells.
    Stem cells and development, 2015, Feb-01, Volume: 24, Issue:3

    Topics: Animals; Animals, Genetically Modified; Benzamides; Blastocyst; Cattle; Cells, Cultured; CRISPR-Cas Systems; Diphenylamine; Fertilization in Vitro; Fibroblasts; Gene Knock-In Techniques; Genetic Engineering; Genetic Enhancement; Genetic Loci; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Homologous Recombination; Induced Pluripotent Stem Cells; Mice; Mice, SCID; Polymorphism, Restriction Fragment Length; Pyridines; Pyrimidines; Recombinant Fusion Proteins; Teratoma; Transcription Factors; Valproic Acid

2015
Combination of SB431542, CHIR99021 and PD0325901 has a synergic effect on abrogating valproic acid‑induced epithelial‑mesenchymal transition and stemness in HeLa, 5637 and SCC‑15 cells.
    Oncology reports, 2019, Volume: 41, Issue:6

    Topics: Benzamides; Dioxoles; Diphenylamine; Drug Synergism; Epithelial-Mesenchymal Transition; HeLa Cells; Humans; Neoplasms; Neoplastic Stem Cells; Pyridines; Pyrimidines; Valproic Acid

2019